ENTITY Beilu Pharmaceutical

Beilu Pharmaceutical

PulseAugur coverage of Beilu Pharmaceutical — every cluster mentioning Beilu Pharmaceutical across labs, papers, and developer communities, ranked by signal.

Show in brief

Total · 30d

1 over 90d

Releases · 30d

0 over 90d

Papers · 30d

0 over 90d

TIER MIX · 90D

TOPICS

funding 1
product 1

SENTIMENT · 30D

1 day(s) with sentiment data

RECENT · PAGE 1/1 · 1 TOTAL

RESEARCH · CL_26214 · May 11 · 08:06

Xiamen Xiangyu to issue 10B yuan bonds; Beilu Pharma's contrast agent approved

Xiamen Xiangyu has received approval from the China Securities Regulatory Commission to issue corporate bonds totaling no more than 10 billion yuan to professional investors. Separately, Beilu Pharmaceutical announced t…

Xiamen Xiangyu to issue 10B yuan bonds; Beilu Pharma's contrast agent approved